Phase I Study of GW642444M in Healthy Japanese Male Subjects
NCT00964249
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GW642444
DRUG:
Placebo
Sponsor
GlaxoSmithKline